JP2003502278A5 - - Google Patents

Download PDF

Info

Publication number
JP2003502278A5
JP2003502278A5 JP2000593602A JP2000593602A JP2003502278A5 JP 2003502278 A5 JP2003502278 A5 JP 2003502278A5 JP 2000593602 A JP2000593602 A JP 2000593602A JP 2000593602 A JP2000593602 A JP 2000593602A JP 2003502278 A5 JP2003502278 A5 JP 2003502278A5
Authority
JP
Japan
Prior art keywords
alkoxy
alkyl
hydrogen
substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000593602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003502278A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/000192 external-priority patent/WO2000042034A1/en
Publication of JP2003502278A publication Critical patent/JP2003502278A/ja
Publication of JP2003502278A5 publication Critical patent/JP2003502278A5/ja
Withdrawn legal-status Critical Current

Links

JP2000593602A 1999-01-15 2000-01-13 新規のn−オキシド Withdrawn JP2003502278A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100693 1999-01-15
EP99100693.3 1999-01-15
PCT/EP2000/000192 WO2000042034A1 (en) 1999-01-15 2000-01-13 Phenanthridine-n-oxides with pde-iv inhibiting activity

Publications (2)

Publication Number Publication Date
JP2003502278A JP2003502278A (ja) 2003-01-21
JP2003502278A5 true JP2003502278A5 (cg-RX-API-DMAC7.html) 2007-03-01

Family

ID=8237350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000593602A Withdrawn JP2003502278A (ja) 1999-01-15 2000-01-13 新規のn−オキシド

Country Status (12)

Country Link
US (1) US6534519B1 (cg-RX-API-DMAC7.html)
EP (1) EP1147103B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003502278A (cg-RX-API-DMAC7.html)
AT (1) ATE294793T1 (cg-RX-API-DMAC7.html)
AU (1) AU2290000A (cg-RX-API-DMAC7.html)
CA (1) CA2359449A1 (cg-RX-API-DMAC7.html)
DE (1) DE60019894T2 (cg-RX-API-DMAC7.html)
DK (1) DK1147103T3 (cg-RX-API-DMAC7.html)
ES (1) ES2241571T3 (cg-RX-API-DMAC7.html)
PT (1) PT1147103E (cg-RX-API-DMAC7.html)
SI (1) SI1147103T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000042034A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05105B1 (et) * 1999-01-15 2008-12-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenlfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
WO2001051470A1 (en) 2000-01-11 2001-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides
SI1303506T1 (en) 2000-07-14 2005-06-30 Altana Pharma Ag 6-heteroarylphenanthridines
AU2003255493B8 (en) * 2002-08-29 2009-03-26 Takeda Gmbh 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
CA2496459C (en) * 2002-08-29 2013-06-25 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
EP1658270A1 (en) * 2003-07-31 2006-05-24 ALTANA Pharma AG Novel 6-phenylphenantridines
JP2007500686A (ja) * 2003-07-31 2007-01-18 アルタナ ファルマ アクチエンゲゼルシャフト 新規の6−フェニルフェナントリジン
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2005023253A1 (en) * 2003-09-05 2005-03-17 Altana Pharma Ag Use of pde4 inhibitors for the treatment of diabetes mellitus
EP1720835B1 (en) 2004-02-18 2012-12-12 Nycomed GmbH Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
MXPA06009892A (es) * 2004-03-10 2007-03-01 Altana Pharma Ag Nuevas hidroxi-6-fenilfenantridinas sustituidas con amido y su uso como inhibidores de la fosfodiesterasa tipo 4 (pde4).
ES2337083T3 (es) 2005-03-02 2010-04-20 Nycomed Gmbh (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1.
CN102600144A (zh) 2005-03-08 2012-07-25 奈科明有限责任公司 治疗糖尿病的罗氟司特
KR101178674B1 (ko) 2007-10-04 2012-08-30 에프. 호프만-라 로슈 아게 사이클로프로필 아릴 아마이드 유도체 및 이의 용도
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines
US5475003A (en) * 1994-03-03 1995-12-12 Syntex (U.S.A.) Inc. 8-phenylcyclopentenoquinoline and 8-phenylcyclohexenoquinoline derivatives
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
EE03523B1 (et) 1996-01-31 2001-10-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
CA2250569C (en) * 1996-03-26 2005-05-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel phenanthridines substituted in the 6 position
GB9622386D0 (en) 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
DK0937074T3 (da) 1996-11-11 2003-06-23 Altana Pharma Ag Benzonaphthyridiner som bronkiale terapeutiske midler
GB9626643D0 (en) 1996-12-21 1997-02-12 Astra Pharma Prod Compounds
SI0968211T1 (en) * 1997-03-07 2004-02-29 Altana Pharma Ag Tetrazole derivatives
AU8106598A (en) 1997-06-03 1998-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
AU753615B2 (en) 1997-07-25 2002-10-24 Altana Pharma Ag Novel tetrazole derivatives
SI1109810T1 (en) 1998-08-31 2004-12-31 Altana Pharma Ag Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity

Similar Documents

Publication Publication Date Title
JP2002506856A5 (cg-RX-API-DMAC7.html)
JP2002534508A5 (cg-RX-API-DMAC7.html)
CA2373653C (en) New use of compounds as antibacterial agents
JP2002517491A5 (cg-RX-API-DMAC7.html)
JP2003501474A5 (cg-RX-API-DMAC7.html)
EP1236719A4 (en) NOVEL HETEROCYCLIC COMPOUNDS AND SALTS THEREOF, USE OF THESE COMPOUNDS IN MEDICINE
JP2006508913A5 (cg-RX-API-DMAC7.html)
JP2006500370A5 (cg-RX-API-DMAC7.html)
JP2003500442A5 (cg-RX-API-DMAC7.html)
WO2004113270A3 (en) Propionic acid derivatives useful in the treatment of lipid disorders
JP2008509187A5 (cg-RX-API-DMAC7.html)
JP2010529147A5 (cg-RX-API-DMAC7.html)
DK0893998T4 (da) Afgivelse af nikotin i tyktarmen med henblik på behandling af inflammatoriske tarmsygdomme
JP2007517043A5 (cg-RX-API-DMAC7.html)
JP2002534506A5 (cg-RX-API-DMAC7.html)
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
JP2002534507A5 (cg-RX-API-DMAC7.html)
NO20050569L (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
ATE479433T1 (de) Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
KR960022472A (ko) 3-페닐이소퀴놀-1(2h)-온 유도체와 그것의 제법 및 치료학적 이용
WO2000068198A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
EP1184034A3 (en) Oral drug composition containing a verapamil derivative as a drug-absorption promotor
JP2001520994A5 (cg-RX-API-DMAC7.html)
WO2003082329A3 (en) Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
JP2004315496A5 (cg-RX-API-DMAC7.html)